
1. Technology overview
Tucuvi Care, S.L. is a healthcare AI company with its legal address in Madrid, Spain and a US entity, Tucuvi Health, Inc. in New York. Founded by Maria Gonzalez (CEO) and Marcos Rubio (CTO), it addresses the limited capacity of care teams to follow up with patients between visits.
LOLA is a clinical voice AI agent that calls and receives calls from patients following workflows defined by each organization, such as post-discharge follow-up, reminders and access management. A hybrid architecture uses models to interpret answers, explicit protocol rules to govern permitted actions and escalation, and an AI Sentinel layer that checks completed interactions before results reach clinicians in the Tucuvi Dashboard. Customers include hospitals, health systems and pharma companies.
2. Highlighted features & specifications
- Outbound outreach: Proactively contacts patients for follow-ups, reminders and program tasks.
- Inbound requests: Handles incoming calls within program scope and escalates clinical questions.
- Retry rules: Configurable call frequency, voicemail handling and team review when contact fails.
- Omnichannel: Combines phone and text.
- AI Sentinel: Screens completed interactions for errors before clinicians see them.
- Clinician dashboard: Teams review each interaction in the Tucuvi Dashboard.
3. Potential application
A Vietnamese hospital could call heart failure or COPD patients after discharge to detect warning signs. A pharma company could run adherence check-ins for patients on long-term therapy.
4. Benefits
Patients need no app or portal and can answer in their preferred language. Care teams review each interaction in one dashboard. The funding announcement reports over 300,000 patient calls completed and more than 60 healthcare organisations served.
5. Market trends & opportunities
Health systems are adopting voice AI agents to extend nursing follow-up for chronic and post-discharge patients. Vietnam's aging population and overloaded hospitals create similar demand for scalable telephone follow-up, though language support would need localisation.
6. Other information
Tucuvi Care, S.L., Calle Hermosilla 48, Madrid (tax ID B95969705); US entity Tucuvi Health, Inc., New York. Series A of USD 20 million announced 8 January 2026 with Frontline Ventures, Seaya Ventures and Shilling as existing backers. Site shows a CE mark logo. Founding year not stated on fetched pages.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































